Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
MAZE
MAZE
Operating margin
Operating margin at other companies
Vertex Pharmaceuticals
VRTX
38.3%
—
Septerna, Inc.
SEPN
-77.1%
-38.4pp
Stoke Therapeutics, Inc.
STOK
-577.5%
-597pp
Zymeworks
ZYME
-140.4%
+7.3pp
Nurix Therapeutics, Inc.
NRIX
-439.3%
+35.3pp
Relay Therapeutics, Inc.
RLAY
-2,776.6%
-820pp
Other financials
Income statement
See full
Revenue
$20.0M
—
Operating income
-$26.6M
+25.0%
Net income
-$24.2M
+26.2%
EPS (diluted)
-$0.45
+60.9%
Balance sheet
See full
Cash & equivalents
$198.8M
-32.5%
Total debt
$61.2M
+137%
Total equity
$341.7M
+17.0%
Total assets
$419.7M
+26.1%
Cash flow
See full
Operating cash flow
-$39.1M
-32.5%
CapEx
$93.0K
-68.9%
Free cash flow
-$39.2M
-31.5%
Valuation
See full
Market cap
$1.48B
—
Enterprise value
$1.34B
—
P/S
7.9×
—
Profitability
See full
Net margin
-65.4%
—
FCF margin
-65.1%
—
Returns & leverage
See full
Return on equity
-38.7%
—
Debt / equity
0.2×
+0.1×
Current ratio
17.9×
+1.8×